BETA
BETA
Innoviva
INVA67
$18.55arrow_drop_up1.97%$0.36
INVA67
$18.55
arrow_drop_up1.97%Performance History
| Key Stats | |
|---|---|
| Open | $18.44 |
| Prev. Close | $18.19 |
| EPS | 2.24 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 18.27 | 18.44 |
| 52 Week Range | 12.22 | 18.56 |
| Ratios | |
|---|---|
| EPS | 2.24 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Correlated Companies
About Innoviva (INVA)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Headquarters
- Burlingame
- Employees
- 101
- Exchange
- NASDAQ
Keep an eye on Innoviva
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is the market capitalization of Innoviva (INVA)?
Innoviva (INVA) has a market capitalization of $1.14B. The average daily trading volume is 636.95K, indicating the stock's liquidity and investor engagement.
help
What is Innoviva 's (INVA) price per share?
The current price per share for Innoviva (INVA) is $18.55. The stock has seen a price change of $0.36 recently, indicating a 1.98% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Innoviva (INVA)?
For Innoviva (INVA), the 52-week high is $18.7, which is 0.81% from the current price. The 52-week low is $12.22, the current price is 51.8% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Innoviva (INVA) a growth stock?
Innoviva (INVA) has shown an average price growth of 0.41% over the past three years. It has received a score of 77 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Innoviva as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Innoviva (INVA) stock price performance year to date (YTD)?
As of the latest data, Innoviva (INVA) has a year-to-date price change of 13.32%. Over the past month, the stock has experienced a price change of 14.93%. Over the last three months, the change has been 23.75%. Over the past six months, the figure is 12.29%. Looking at a longer horizon, the five-year price change stands at 65.48%.
help
Is Innoviva (INVA) a profitable company?
Innoviva (INVA) has a net income of $179.72M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 75.84% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 33.3% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $324.26M, although specific revenue growth data is currently not available. The gross profit is $245.92M. Operating income is noted at $113.88M. Furthermore, the EBITDA is $243.12M.
News
NEWS
ANALYST COLOR
BIOTECH
EQUITIES
HEALTH CARE
INITIATION
ANALYST RATINGS
TRADING IDEAS
GENERAL
6/18/2024Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs
3/2/2024
10 stocks you can bet on being inflation-proof
5/24/2023
FDA approves Innoviva’s bacterial pneumonia treatment
LONG IDEAS
NEWS
SMALL CAP
INSIDER TRADES
PRE-MARKET OUTLOOK
MARKETS
TRADING IDEAS
5/16/2023Over $125M Bet On Occidental Petroleum? Check Out These 4 Stocks Insiders Are Buying
4/18/2023
J&J (JNJ) Q1 Earnings & Sales Top, 2023 View Up, Stock Rises
4/17/2023
Is Innoviva (INVA) Stock Undervalued Right Now?
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.